Contact us

The patent landscape behind the Nobel Prize awarded to CRISPR

The 2020 Nobel Prize in Chemistry was awarded to Jennifer Doudna and Emmanuelle Charpentier in October for their work on the gene editing tool CRISPR/Cas 9, commonly referred to as CRISPR.

This Nobel Prize does not come without some controversy. Not only are the winners involved in a patent dispute relating to CRISPR, where Doudna’s and Charpentier’s interests are represented by the University of California while Feng Zhang, on the other side of the patent dispute, is active at The Broad Institute of MIT and Harvard and was notably not included in the award by the Nobel committee.

We have looked into the patents behind the CRISPR technology and discovered who the key players are in this space and how this is impacting the patent landscape.

Our article explores some of the following key findings:

  • The potential of CRISPR is undisputed, but who controls the patent assets?
  • Although universities are still in control of some of the largest patent portfolios relating to the CRISPR tool, commercial organisations are actively using and patenting this technology.
  • DuPont De Nemours and Regeneron Pharmaceuticals have comparatively small portfolios, but they are equally as important to the Harvard, MIT and Broad Institute portfolios.

If you’d like to learn more about how Cipher has enabled this Competitive Intelligence analysis, get in touch contact us directly.

Download ‘CRISPR Nobel Prize’ PDF

Insights and Events

Benchmarking your patent portfolio Key Findings

Do you think benchmarking is necessary to manage your portfolio? What metrics do you use to benchmark? Are you finding it hard to communicate the value of your patent portfolio?
Read more


ANT Group, the Alibaba FinTech giant is going for an IPO but what does its patent portfolio focus on?
Read more

Analog Devices buys Maxim

Analog Devices acquisition of Maxim Integrated confirmed in an all-stock transaction valued at US$21 billion. What does this mean for the analog semiconductor industry?
Read more

Banking Cybersecurity webinar

26 May 2020, 3:00pm BST View our webinar on Banking Cybersecurity where Cipher will shed light on key innovations helping reduce our exposure to online risks.
Read more

Ams completes acquisition of Osram

Ams had final approval to buy OSRAM, but what does this mean for their patent portfolio?
Read more

Fintech – Understanding the role of patents

Technologies that will disrupt and transform the future of banking
Read more

With Cipher you can…

Portfolio Optimisation connecting cogs

Optimise your portfolio

Ensure you have the right portfolio to meet your strategic patenting objectives.

Read more
Competitive Intelligence

Gather competitor intelligence

Understand who’s doing what by automating patent to technology mapping.

Read more
Cross Licensing

Model cross licensing

Combine patent and revenue data to determine rational licensing outcomes.

Read more

Manage your budget

Justify patent budgets to CFOs and communicate the impact of your investment.

Read more

Conduct due diligence

Automate manual reviews for efficient execution of M&A and licensing transactions.

Read more

Tackle inbound patent assertion

Be prepared with evidence to create a fast and effective threat assessment.

Read more

Benchmark your portfolio

Assess your portfolio in comparison to other owners through your technology lens.

Read more

Monetise your portfolio

Identify opportunities to create value through licensing or sale of patent assets.

Read more
Technology Trends icon

Predict technology trends

Track today’s new technologies and discover the unknown owners of future disruptive innovation.

Read more

Improve your patent strategy now

Speak to the Cipher team today.